Menactra: Clinical Trials

3 trials of Menactra, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 13Completed 3

Follow Menactra: new trials by email Literature Review of Menactra trials Research Report on Menactra

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Immunogenicity of Pfs25M-EPA/AS01 and Pfs230D1M-EPA/AS01 Vaccines, Transmission Blocking Vaccines Against Plasmodium Falciparum, at Full and Fractional Dosing in Adults in Mali
Pfs25M-EPA, Pfs230D1M-EPA, AS01 - Malaria
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)3012016-10-212024-12-10
Study of the Safety and Immunogenicity of Pfs230D1M-EPA/Alhydrogel and Pfs25M-EPA/Alhydrogel , a Transmission Blocking Vaccine Against Plasmodium Falciparum Malaria, in Adults in the U.S. and Mali
Pfs230D1M-EPA/Alhydrogel, Pfs25M-EPA/Alhydrogel, TWINRIX - Malaria
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)5382015-01-072019-04-11
Testing Pfs25-EPA/Alhydrogel as a Potential Malaria Transmission Blocking Vaccine
Pfs25-EPA/Alhydrogel, Euvax B, Menactra - Malaria
Phase 1CompletedNational Institute of Allergy and Infectious Diseases (NIAID)2302013-03-272018-07-05

Conditions studied

Malaria (3)

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID) (3)

Countries

Mali (3)  ·  United States (1)

Top investigators

Patrick E Duffy, M.D. (2)  ·  Sara A Healy, M.D. (1)

Results publications

PMID 39787798, PMID 30061051, PMID 31307393, PMID 33561016, PMID 37027391, PMID 37499679, PMID 40552966